About deepCDR Biologics
deepCDR Biologics is a company based in Basel (Switzerland) founded in 2019 by Sai Reddy was acquired by Alloy Therapeutics in December 2021. deepCDR Biologics operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
- Headquarter Basel, Switzerland
- Founders Sai Reddy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Alloy Therapeutics
(Dec 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of deepCDR Biologics
Detailed funding history for deepCDR Biologics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in deepCDR Biologics
deepCDR Biologics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alloy Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided for therapeutic development.
|
Locked | Locked | Locked |
Investor details for deepCDR Biologics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by deepCDR Biologics
Investment portfolio details for deepCDR Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - deepCDR Biologics
Detailed financials for deepCDR Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Deepcdr Biologics Comparisons
Peer comparison for deepCDR Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of deepCDR Biologics
deepCDR Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
|
| Locked | Locked | Locked |
Small molecule oncology therapeutics are developed for cancer treatment.
|
Detailed competitors of deepCDR Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Deepcdr Biologics
Complete news archive for deepCDR Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about deepCDR Biologics
deepCDR Biologics was founded in 2019.
deepCDR Biologics is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
deepCDR Biologics was founded in 2019 in Basel, Switzerland, with Sai Reddy serving as co-founder. Diagnostic and pharmaceutical products are developed and produced by the company within the biologics sector. Operations are centered on healthcare applications, including testing and treatment solutions. The focus remains on manufacturing processes tailored to medical needs, supported by a presence in the European pharmaceutical landscape.
deepCDR Biologics's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.
deepCDR Biologics has 1 investor. Key investors include Alloy Therapeutics.